• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有异质性功能模式的家族性垂体腺瘤:临床和遗传特征

Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features.

作者信息

Raverot G, Arnous W, Calender A, Trouillas J, Sassolas G, Bournaud C, Pugeat M, Borson-Chazot F

机构信息

Fédération d'Endocrinologie du Pôle Est, Hospices Civils de Lyon, Lyon, France.

出版信息

J Endocrinol Invest. 2007 Oct;30(9):787-90. doi: 10.1007/BF03350819.

DOI:10.1007/BF03350819
PMID:17993773
Abstract

Familial pituitary adenoma is a rare syndrome which may present either as isolated lesions, or in association with other endocrine tumors, for example in the frame of multiple endocrine neoplasia (MEN-1) or Carney complex (CNC). The most frequently described forms of familial isolated pituitary adenoma (FIPA) are familial somatotropinomas or prolactinomas. Recently, some cases of familial isolated somatotropinoma have been associated with germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. The present report shows heterogeneous FIPA with 3 subtypes of tumor in 3 individuals of the same family: somatotropinoma in the proband, giant prolactinoma in a brother, and gonadotroph cell macroadenoma in the father. A prospective survey also suggested the occurrence of a silent microadenoma in the proband's sister. Clinical screening was performed in the 3 affected members, the 4th suspected case, and 9 additional, asymptomatic relatives. They had no clinical evidence of associated endocrine lesion suggesting MEN-1 or CNC. Genetic screening for germline mutation of the MEN-1, the gene encoding the protein kinase A (PKA) type 1 alpha regulatory subunit (R1 alpha) (PRKAR1alpha) and AIP gene was negative in 2 affected members. In conclusion, these data suggest that familial pituitary adenomas can occur with a heterogeneous functional pattern that is distinguished from MEN-1 or CNC. The absence of mutation of the recently described AIP gene suggests the implication of other predisposing gene(s). Collaborative, multicentric studies are needed to further define the location of gene(s) involved in heterogeneous FIPA.

摘要

家族性垂体腺瘤是一种罕见的综合征,可表现为孤立性病变,或与其他内分泌肿瘤相关,例如在多发性内分泌腺瘤病1型(MEN-1)或卡尼综合征(CNC)的情况下。最常描述的家族性孤立性垂体腺瘤(FIPA)形式是家族性生长激素瘤或催乳素瘤。最近,一些家族性孤立性生长激素瘤病例与芳烃受体相互作用蛋白(AIP)基因的种系突变有关。本报告显示了一个家族中3名个体的异质性FIPA,有3种肿瘤亚型:先证者为生长激素瘤,其兄弟为巨大催乳素瘤,父亲为促性腺激素细胞大腺瘤。一项前瞻性调查还提示先证者的妹妹存在无症状微腺瘤。对3名患病成员、第4名疑似病例以及另外9名无症状亲属进行了临床筛查。他们没有提示MEN-1或CNC的相关内分泌病变的临床证据。对MEN-1、编码蛋白激酶A(PKA)1型α调节亚基(R1α)(PRKAR1α)的基因和AIP基因进行种系突变的基因筛查,结果在2名患病成员中为阴性。总之,这些数据表明家族性垂体腺瘤可呈现异质性功能模式,与MEN-1或CNC不同。最近描述的AIP基因未发生突变提示其他易感基因的参与。需要开展协作性多中心研究,以进一步明确参与异质性FIPA的基因定位。

相似文献

1
Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features.具有异质性功能模式的家族性垂体腺瘤:临床和遗传特征
J Endocrinol Invest. 2007 Oct;30(9):787-90. doi: 10.1007/BF03350819.
2
The clinical, pathological, and genetic features of familial isolated pituitary adenomas.家族性孤立性垂体腺瘤的临床、病理及遗传学特征。
Eur J Endocrinol. 2007 Oct;157(4):371-82. doi: 10.1530/EJE-07-0348.
3
Clinical characterization of familial isolated pituitary adenomas.家族性孤立性垂体腺瘤的临床特征
J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23. doi: 10.1210/jc.2005-2671. Epub 2006 Jun 20.
4
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.家族性孤立性垂体腺瘤(FIPA)和由于芳香烃受体相互作用蛋白(AIP)基因突变引起的垂体腺瘤易感性。
Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31.
5
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.家族性孤立性垂体腺瘤中芳烃受体相互作用蛋白基因突变:73个家系的分析
J Clin Endocrinol Metab. 2007 May;92(5):1891-6. doi: 10.1210/jc.2006-2513. Epub 2007 Jan 23.
6
[Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas].[一例三人家庭性孤立性垂体腺瘤伴均匀催乳素瘤的临床与遗传学研究]
Medicina (B Aires). 2020;80(2):181-184.
7
Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.家族性垂体肿瘤的最新进展:从1型多发性内分泌腺瘤病到家族性孤立性垂体腺瘤。
Horm Res. 2009 Jan;71 Suppl 1:105-11. doi: 10.1159/000178050. Epub 2009 Jan 21.
8
[Familial pituitary adenomas].[家族性垂体腺瘤]
Presse Med. 2009 Jan;38(1):112-6. doi: 10.1016/j.lpm.2008.09.011. Epub 2008 Nov 5.
9
[Familial pituitary adenomas: clinical and genetic aspects].
Ann Endocrinol (Paris). 2007 Jun;68 Suppl 1:9-11. doi: 10.1016/s0003-4266(07)80003-5.
10
Familial pituitary tumors.家族性垂体瘤
Handb Clin Neurol. 2014;124:339-60. doi: 10.1016/B978-0-444-59602-4.00023-X.

引用本文的文献

1
Dopamine agonist resistant prolactinomas: any alternative medical treatment?多巴胺激动剂抵抗型催乳素瘤:有其他替代的医学治疗方法吗?
Pituitary. 2020 Feb;23(1):27-37. doi: 10.1007/s11102-019-00987-3.
2
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.家族性孤立性垂体腺瘤(FIPA)和由于芳香烃受体相互作用蛋白(AIP)基因突变引起的垂体腺瘤易感性。
Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31.

本文引用的文献

1
High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.垂体腺瘤的高患病率:比利时列日省的一项横断面研究。
J Clin Endocrinol Metab. 2006 Dec;91(12):4769-75. doi: 10.1210/jc.2006-1668. Epub 2006 Sep 12.
2
Clinical characterization of familial isolated pituitary adenomas.家族性孤立性垂体腺瘤的临床特征
J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23. doi: 10.1210/jc.2005-2671. Epub 2006 Jun 20.
3
Pituitary adenoma predisposition caused by germline mutations in the AIP gene.AIP基因种系突变引起的垂体腺瘤易感性。
Science. 2006 May 26;312(5777):1228-30. doi: 10.1126/science.1126100.
4
Clinical and genetic features of familial pituitary adenomas.家族性垂体腺瘤的临床和遗传特征
Horm Metab Res. 2005 Jun;37(6):347-54. doi: 10.1055/s-2005-870135.
5
Pituitary pathology in Carney complex patients.卡尼综合征患者的垂体病理学
Pituitary. 2004;7(2):73-82. doi: 10.1007/s11102-005-5348-y.
6
Minireview: PRKAR1A: normal and abnormal functions.综述:PRKAR1A:正常与异常功能
Endocrinology. 2004 Dec;145(12):5452-8. doi: 10.1210/en.2004-0900. Epub 2004 Aug 26.
7
Familial acromegaly.家族性肢端肥大症
Growth Horm IGF Res. 2004 Jun;14 Suppl A:S90-6. doi: 10.1016/j.ghir.2004.03.021.
8
Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.1型多发性内分泌腺瘤病(MEN1)中的垂体疾病:来自法国-比利时MEN1多中心研究的数据。
J Clin Endocrinol Metab. 2002 Feb;87(2):457-65. doi: 10.1210/jcem.87.2.8145.
9
Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.卡尼综合征患者中PRKAR1A基因的遗传异质性和突变谱
Hum Mol Genet. 2000 Dec 12;9(20):3037-46. doi: 10.1093/hmg/9.20.3037.
10
Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex.蛋白激酶A R1α调节亚基的突变会导致家族性心脏黏液瘤和卡尼综合征。
J Clin Invest. 2000 Sep;106(5):R31-8. doi: 10.1172/JCI10841.